Abstract:Portal vein involvement is considered one of the most fearful complications of hepatocellular carcinoma (HCC). Portal vein tumor thrombosis (PVTT) is associated with aggressive tumor biology (high grade), high tumor burden (number and size of lesions), high levels of serum markers (AFP), poor liver function (deranged LFT), and poor performance status of patients. The Barcelona Clinic Liver Cancer staging system places HCC patients with PVTT in advanced stage (BCLC Stage-C). This group contains a fairly heterogeneous patient population, previously considered candidates for palliative systemic therapy with sorafenib. However, this provided modest overall survival (OS) benefit. The results of a recent Phase III (IMbrave150) trial favor the combination of atezolizumab and bevacizumab over sorafenib as a standard of care in advanced unresectable HCC. While only lenvatinib proved to be non-inferior against sorafenib in a phase III (REFLECT trial), regorafenib (RESORCE trial), ramucirumab (REACH-2), and cabozantinib (CELESTIAL) have been approved second-line therapy in phase III clinical trials. Recently, the data on the prospect of other modalities in the management of HCC with PVTT is mounting with favorable results. Targeting multiple pathways in the HCC cascade using a combination of drugs and other modalities such as RT, TACE, TARE, and HAIC appear effective for systemic and loco-regional control. The quest for the ideal combination therapy and the sequence set is still widely unanswered and prospective trials are lacking. With the armament of available therapeutic options and the advances and refinements in the delivery system, down-staging patients to make them eligible for curative resection has been reported. In a rapidly evolving treatment landscape, performing surgery when appropriate, in the form of LR and even LT to achieve cure does not seem farfetched. Likewise, adjuvant therapy and prompt management of the recurrences holds the key to prolong OS and DFS. This review discusses the management options of HCC patients with PVTT.

Portal Vein Tumor Thrombosis and Hepatocellular Carcinoma - The Changing Tides

The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy

Treatment of hepatocellular carcinoma with portal venous tumor thrombosis: A comprehensive review

Portal Vein Tumor Thrombus is a Bottleneck in the Treatment of Hepatocellular Carcinoma

Recent advances in treatment strategies for hepatocellular carcinoma with portal vein cancer thrombus

Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy

New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

Liver transplantation for advanced hepatocellular carcinoma: Controversy over portal vein tumor thrombosis

Surgical Strategy For Hepatocellular Carcinoma Patients With Portal/Hepatic Vein Tumor Thrombosis

Surgical Resection for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in the Asia-Pacific Region Beyond the Barcelona Clinic Liver Cancer Treatment Algorithms: a Review and Update

[Progress in Surgical Treatment of Hepatocellular Carcinoma with Tumor Thrombus in the Inferior Vena Cava].

Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis.

Surgical Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

Multimodality Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Therapy choices for patients of hepatocellular carcinoma complicated with portal vein tumor thrombi

Recent Advances on the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Hepatocellular Carcinoma Associated with Tumor Thrombosis in the Portal Vein: the Effects of Different Treatments.

Treatment of hepatocellular carcinoma in patients with portal vein tumor thrombosis: Beyond the known frontiers

[Hepatic Resection with Removal of Tumor Thrombi for Hepatocellular Carcinoma with Tumor Thrombi in Portal Vein and Curative Analysis].

Efficacy of Different Treatment Strategies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis